Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ASCPT In Brief

This article was originally published in The Tan Sheet

Executive Summary

Tylenol use in alcoholics: The recommendation by some practitioners that alcoholics avoid use of acetaminophen or decrease their daily dose "is not supported by prospective data," Edwin Kuffner, MD, Rocky Mountain Poison & Drug Center, Denver Colo., et al., find. The prospective placebo-controlled trial was presented at the American Society for Clinical Pharmacology & Therapeutics annual meeting in Orlando, Fla. March 2-5. The authors followed 385 alcoholics for three days, giving 262 of the patients 4 g/day of acetaminophen while the other 123 patients received placebo. "Alcoholics treated with the maximal daily recommended dose of [acetaminophen] for three days did not develop liver injury," the authors maintain...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts